2016
DOI: 10.1007/s00403-016-1655-6
|View full text |Cite
|
Sign up to set email alerts
|

SATB2 is expressed in Merkel cell carcinoma

Abstract: Merkel cell carcinoma (MCC) is a rare aggressive skin cancer with neuroendocrine differentiation. With immunohistochemistry, the tumor cells stain for both neuroendocrine (i.e., synaptophysin and chromogranin A) and epithelial markers. The epithelial marker cytokeratin 20 (CK20) stains positive with immunohistochemistry in a vast majority of MCCs. The expression of the special AT-rich sequence-binding protein (SATB2) was analyzed in MCC (n = 20) together with other forms of skin cancer and neuroendocrine tumor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
34
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(34 citation statements)
references
References 11 publications
0
34
0
Order By: Relevance
“…; Fukuhara et al. ). We demonstrated they are CK20, which is in line with the epithelial (Morrison et al.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…; Fukuhara et al. ). We demonstrated they are CK20, which is in line with the epithelial (Morrison et al.…”
Section: Discussionmentioning
confidence: 97%
“…; Fukuhara et al. ]. Non‐specific binding was reduced by incubating the sections for 30 min with a solution of 25% calf bovine serum in Tris buffer solution (TBS).…”
Section: Methodsmentioning
confidence: 99%
“…reported SATB2 positivity in 40% of ‘carcinoids’, not further specified . This same group reported no staining in 10 ‘carcinoids’ in a subsequent study focused on SATB2 expression in NECs . Lin et al .…”
Section: Discussionmentioning
confidence: 98%
“…In addition to colorectal cancer, SATB2 expression has also been described recently in other tumours, including carcinomas of the gastrointestinal tract such as small intestinal carcinoma, appendical mucinous neoplasm, pancreatic adenocarcinoma and oesophageal squamous cell carcinoma, as well as neoplasms of neuroectodermal and mesenchymal origin; for example, Merkel cell carcinoma, neuroendocrine tumours and osteosarcoma . However, as > 85% of CRC were SATB2‐positive in two large studies comprising > 1800 and > 100 CRC cases in total, this marker has been advocated to determine colorectal origin .…”
Section: Discussionmentioning
confidence: 99%